Colonics
About Me
Recent Posts
- 'Personality Genes' May Help Account For Longevity
- 4 Mushroom Poisonings In 2 Weeks - Doctors Test Milk Thistle As Treatment
- Improved Diagnostics For Sleeping Sickness
- Prostate Growth May Be Slowed By Statins
- New Tools For Psychological Science Research - Facebook And Smartphones
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Friends
Links
Entry 1 of 2381
Last Page | Next Page
5/11/2009
-
Studies Of GARDASIL(R), Merck's Cervical Cancer Vaccine, And HPV 16 Vaccine Component Of GARDASIL Presented At International Papillomavirus Conference
|
In a study of an expansive follow up of 290 women naïve to HPV type 16, the HPV 16 incorporated of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 impurity for an average of 8.5 years after administration. The women enrolled in this study are a subset of the novel Phase II HPV 16 proof-of-concept study published in 2002. More: - Brought to my attention by |
Post A Comment! :: Send to a Friend! |
Share and enjoy
